SIM
REGN icon

Sonora Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Sonora Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-10
Closed -$3K – 1806
2019
Q2 		$3K Buy
+10
New +$3.33K ﹤0.01% 1522
2015
Q4 		– Sell
-17
Closed -$8K – 1079
2015
Q3 		$8K Buy
+17
New +$9.13K ﹤0.01% 560

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Sonora Investment Management's REGN Position: Q3 2019 in Review

Sonora Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2019, closing a stake of 10 shares — an estimated $3K sold.

Sonora Investment Management first reported a position in REGN in Q3 2015 and held it in 2 quarters. The position peaked at $8K in Q3 2015. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

  • Sonora Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Sonora Investment Management sold 10 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $3K.
  • Sonora Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Sonora Investment Management's Regeneron Pharmaceuticals position peaked at $8K in Q3 2015.
  • 633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Sonora Investment Management's 13F filing for Q3 2019, filed 15 Oct 2019.